CAPÍTULO 2: MARCO TEÓRICO
2.2. BASES TEÓRICAS
2.3.3. Aprendizaje Basado en Problemas
1. Geddes M Balzi D Tomatis L (1994) Progress in the fight against cancer in EC countries: changes in mortality rates, 1970-90. Eur J Cancer Prev 3:31-44
2. Bertz,J., Hentschel,S., Hundsdörfer,G. et al. Krebs in Deutschland. 4. überarbeitete, aktualisierte Ausgabe. Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland. Saarbrücken. 2004;
3. Doll R (1996) Nature and nurture: possibilities for cancer control. Carcinogenesis 17:177-184
4. Lagergren J (2005) Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk? Gut 54 Suppl 1:i1-i5
5. Stein HJ von Rahden BHA Höfler H Siewert JR (2003) Karzinom des ösophagogastralen Übergangs und Barrett-Ösophagus. Chirurg 74:703-708
6. Chen XX Yang CS (2001) Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis 22:1119-1129 7. Johnstone RAW Plimmer JR (1959) The chemical constituents of tobacco and tobacco
smoke. Chem Rev 59:885-936
8. Kisaki T Tamaki E (1966) Phytochemical studies of the tobacco alkaloids. X. Degradation of the tobacco alkaloids and their optical rotary changes in tobacco plants. Phytochemistry 5:293-300
9. Leete E Chedekel MR (1972) Aberrant syntheses in higher plants. II. Aberrant formation of (-)-N-methylanabasine from N-methyl-∆1-piperdeinium chloride in
Nicotiana tabacum and N. glauca. Phytochemistry 11:2751-2756
10. Sisler EC (1969) Determination of myosmine with o-aminobenzaldehyde. Anal Biochem 31:183-188
11. Sakuma H Kusama M Yamaguchi K Matsuki T Sugawara S (1984) The distribution of cigarette smoke components between mainstream and sidestream smoke. II. Bases. Beitr Tabakforsch Int 12:199-209
12. Jenkins RA Palausky MA Counts RW Guerin MR Dindal AB Bayne CK (1996) Determination of personal exposure of non-smokers to environmental tobacco smoke in the United States. Lung Cancer 14:S195-S213
13. Benowitz NL (1996) Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev 18:188-204
14. Luanratana O Griffin WJ (1982) Alkaloids of Duboisia hopwoodii. Phytochemistry
21:449-451
15. Lydon J Duke SO (2004) The Potential of Pesticides from Plants. Herbes, Spices, and Medical Plants;Ch. Vol. 4 pp 1-41;
16. Zwickenpflug W Meger M Richter E (1998) Occurrence of the tobacco alkaloid myosmine in nuts and nut products of Arachus hypogaea and Corylus avellana. J
Agric Food Chem 46:2703-2706
17. Tyroller S Zwickenpflug W Richter E (2002) New sources of dietary myosmine uptake from cereals, fruits, vegetables and milk. J Agric Food Chem 50:4909-4915 18. Maier M (2004) Biomonitoring der Myosminbelastung des Menschen in Muttermilch,
Speichel und Plasma. Dissertation an der Medizinischen Fakultät der LMU 19. Brandänge S Lindblom L (1976) N-Vinyl as N-H protection group. A convenient
synthesis of myosmine. Acta Chem Scand 30:39
20. Witkop B (1954) Infrared diagnosis of the hydrochlorides of organic bases. II. The structure of myosmine. Am Chem Soc 76:5597-5599
21. Korte F Schulze-Steinen H-J (1962) Umlagerung von α-Aroyl-pyrrolidonen in konz. Salzsäure zu Pyrrolinderivaten. Chem Ber 95:2444-2452
22. Swain ML Eisner A Woodward CF Brice BA (1949) Ultraviolet absorption spectra of nicotine, nornicotine and some of their derivatives. J Am Chem Soc 71:1341-1345 23. Brandänge S Rodriguez B (1983) Ring chain tautomerism of myosmine. Acta Chem
Scand Ser B 37:643-644
24. Zoltewicz JA Bloom LB Kem WR (1989) Quantitative determination of the ring-chain hydrolysis equilibrium constant for anabaseine and related tobacco alkaloids. J Org Chem 54:4462-4468
25. Ambrose AM DeEds F (1946) Some comparative observations on (-)-nicotine and myosmine. Proc Soc Exp Biol Med 63:423-424
26. Anon (1995) Römpp Chemie Lexikon, CD 1.0. Stuttgart, New York: Georg Thieme Verlag
27. French FA Freedlander BL Furst A (1957) Proc Am Assoc Cancer Res 2:205 28. Riebe M Westphal K Fortnagel P (1982) Mutagenicity testing, in bacterial test
systems, of some constituents of tobacco. Mutat Res 101:39-43
29. Kleinsasser NH Wallner BC Harréus UA Zwickenpflug W Richter E (2003)
Genotoxic effects of myosmine in human lymphocytes and upper aerodigestive tract epithelial cells. Toxicology 192:171-177
30. Machholz R Lewerenz HJ (1989) Lebensmitteltoxikologie. Berlin, Heidelberg: Springer Verlag
31. Marquardt H Schäfer SG (2004) Lehrbuch der Toxikologie. 2; Stuttgart, Germany: Wissenschaftliche Verlagsges.mbH
32. Vermeer ITM (2000) Nitrate exposure and endogenous formation of carcinogenic nitrosamines in humans. Ph D Thesis at the Department of Health Risk and Analytical Toxicology, Maastricht University, Netherlands
33. Spiegelhalder B Eisenbrand G Preussmann R (1976) Influence of dietary nitrate on nitrite content of human saliva: possible relevance to in vivo formation of N-nitroso compounds. Food Chem Toxicol 14:545-548
34. Tannenbaum SR Weisman M Fett D (1976) The effect of nitrate intake on nitrite formation in human saliva. Food Cosmet Toxicol 14:549-552
35. Anon (1981) The health effects of nitrate, nitrite and N-nitroso compounds. Washington DC: National Academy of Sciences National Press
36. Eisenbrand G (1981) N-Nitrosoverbindungen in Nahrung und Umwelt. Eigenschaften, Bildungswege, Nachweisverfahren und Vorkommen. Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH
37. Xu GP Reed PI (1993) N-nitroso compounds in fresh gastric juice and their relation to intragastric pH and nitrite emplying an improved analytical method. Carcinogenesis 14:2547-2551
38. Iijima K Henry E Moriya A Wirz A Kelman AW McColl KEL (2002) Dietary nitrate generates potentially mutagenic concentrations of nitric oxide at the gastroesophageal junction. Gastroenterology 122:1248-1257
39. Moriya A Grant J Mowat C Williams C Carswell A Preston T Anderson S Iijima K McColl KEL (2002) In vitro studies indicate that acid catalysed generation of N- nitrosocompounds from dietary nitrate will be maximal at the gastro-oesophageal junction and cardia. Scand J Gastroenterol 37:253-261
40. Walters CL Hill MJ Rudell WSJ (1978) Gastric juice nitrite. Its source and relationship to hydrogen ion concentration. Environmental aspects of N-nitroso compounds. IARC Sci Publ 19:279-288
41. Koehl W Eisenbrand G (1999) N-nitroso compounds. Toxicology; eds: Marquardt H
Schäfer S Mc Clellan R Welsch F, San Diego, London, Boston, New York, Sydney, Tokio, Toronto, Academic Press
42. Jarosz M Dzieniszewski J Dabrowska-Ufniarz E Wartanowicz M Ziemlanski S (2000) Tobacco smoking and vitamin C concentration in gastric juice in healthy subjects and patients with Helicobacter pylori infection. Eur J Cancer Prev 9:423-428
43. Mirvish SS (1995) Role of N-nitroso compounds (NOC) and N-nitrosation in etiology
of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett 93:17-48
44. Vermeer ITM Moonen EJC Dallinga JW Kleinjans JCS van Maanen JMS (1999) Effect of ascorbic acid and green tea on endogenous formation of N-
nitrosodimethylamine and N-nitrosopiperidine in humans. Mutat Res 428:353-361
45. Tricker AR (1996) Excretion of N-nitrosamines in patients with bacterial bladder infections or diversions of urinary tract. Eur J Cancer Prev 5 (Suppl):95-99 46. Richter E Scherer G (2004) Aktives und passives Rauchen. Lehrbuch der
Toxikologie;Ch. 35 pp 897-918; eds: Marquardt H Schäfer SG, Stuttgart, Germany, Wissenschaftliche Verlagsgesellschaft mbH
47. Eisenbrand G Fuchs A Koehl W (1996) N-Nitroso compounds in cosmetics,
household commodities and cutting fluids. Eur J Cancer Prev 5 (Suppl 1):41-46 48. Stoner GD Gupta A (2001) Etiology and chemoprevention of esophageal squamous
cell carcinoma. Carcinogenesis 22:1737-1746
49. Singer GM Chuan J Roman J Min-Hsin L Lijinsky W (1986) Nitrosamines and nitrosamine precursors in foods from Linxian, China, a high incidence area for esophageal cancer. Carcinogenesis 7:733-736
50. Schneider P Hinrichs S Zulim R Towery R Morris C Mirvish SS (1996)
Carcinogenesis by methylbenzylnitrosamine near the squamocolumnar junction and methylamylnitrosamine metabolism in the mouse forestomach. Cancer Lett 102:125- 131
51. Theisen J Peters JH Fein M Hughes M Hagen JA DeMeester SR DeMeester TR Laird PW (2005) The mutagenic potential of duodenoesophageal reflux. Ann Surg 241:63- 68
52. Zwickenpflug W (2000) N-nitrosation of myosmine yields HPB (4-hydroxy-1-(3-
pyridyl)-1-butanone) and NNN (N-nitrosonornicotine). J Agric Food Chem 48:392-
394
53. Wilp J Zwickenpflug W Richter E (2002) Nitrosation of dietary myosmine as risk factor of human cancer. Food Chem Toxicol 40:1223-1228
54. Staretz ME Foiles PG Miglietta LM Hecht SS (1997) Evidence for an important role of DNA pyridyloxobutylation in rat lung carcinogenesis by 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanone: effects of dose and phenethyl isothiocyanate. Cancer Res 57:259-266
55. Wong HL Murphy SE Hecht SS (2005) Cytochrome P450 2A-catalyzed metabolic activation of structurally similar carcinogenic nitrosamines: N'-nitrosonornicotine enantiomers, N-nitrosopiperidine, and N-nitrosopyrrolidine. Chem Res Toxicol 18:61- 69
56. Ziegel R Shallop A Jones R Tretyakova N (2003) K-ras gene sequence effects on the
formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-DNA adducts. Chem Res Toxicol 16:541-550
57. Hecht SS (1998) Biochemistry, biology, and carcinogenicity of tobacco-specific N-
nitrosamines. Chem Res Toxicol 11:559-603
58. Pegg AE (2000) Repair of O(6)-alkylguanine by alkyltransferases. Mutat Res 462:83- 100
59. Blaise GA Gauvin D Gangal M Authier S (2005) Nitric oxide, cell signaling and cell death. Toxicology 208:177-192
60. Wydra,V. Einfluss reaktiver Spezies auf Membranbestandteile und auf den
Photozyklus von Bacteriorhodopsin Fachbereich Chemie der Technischen Universität Darmstadt; 2001;
61. Denicola A Radi R (2005) Peroxynitrite and drug-dependent toxicity. Toxicology 208:273-288
62. Kim MY Dong M Dedon PC Wogan GN (2005) Effects of peroxynitrite dose and dose rate on DNA damage and mutation in the supF shuttle vector. Chem Res Toxicol
18:76-86
63. Ridnour LA Thomas DD Mancardi D Espey MG Miranda KM Paolocci N Feelisch M Fukuto J Wink DA (2004) The chemistry of nitrosative stress induced by nitric oxide and reactive nitrogen oxide species. Putting perspective on stressful biological situations. Biol Chem 385:1-10
64. Singh RJ Hogg N Joseph J Konorev E Kalyanaraman B (1999) The peroxynitrite generator, SIN-1, becomes a nitric oxide donor in the presence of electron acceptors. Arch Biochem Biophys 361:331-339
65. Tice RR Agurell E Anderson D Burlinson B Hartmann A Kobayashi H Miyamae Y Rojas E Ryu JC Sasaki YF (2000) Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 35:206-221
66. Kleinsasser NH (2004) Toxikologische Bewertung von Inhalationsnoxen:
Testmethoden, Einschätzung der toxischen Wirksamkeit und des Gefahrenspotenzials, Grenzwerte. Laryngo-Rhino-Otol 83:36-53
67. Collins AR Dobson VL Dusinská M Kennedy G Stetina R (1997) The comet assay: what can it really tell us? Mutat Res 375:183-193
68. Hölzle D (2003) Bestimmung von DNA-Addukten tabakspezifischer Nitrosamine in Abhängigkeit von Rauchstatus und Ernährung. Dissertation an der Medizinischen Fakultät der Ludwig-Maximilians-Universität München
69. Cheng KK Sharp L McKinney PA Logan RFA Chilvers CED Cook-Mozaffari P Ahmed A Day NE (2000) A case-control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer 83:127-132
70. Doulias PT Barbouti A Galaris D Ischiropoulos H (2001) SIN-1-induced DNA
damage in isolated human peripheral blood lymphocytes as assessed by single cell gel electrophoresis (comet assay). Free Radic Biol Med 30:679-685
71. Martin-Romero FJ Gutierrez-Martin Y Henao F Gutierrez-Merino C (2004) Fluorescence measurements of steady state peroxynitrite production upon SIN-1 decomposition: NADH versus dihydrodichlorofluorescein and dihydrorhodamine 123. J Fluoresc 14:17-23
72. Buskens CJ Ristimäki A Offerhaus GJA Richel DJ van Lanschot JJB (2003) Role of cyclooxygenase-2 in the development and treatment of oesophageal adenocarcinoma. Scand J Gastroenterol 38 (Suppl 239):87-93
73. Cheong E Ivory K Doleman J Parker ML Rhodes M Johnson IT (2004) Synthetic and naturally occurring COX-2 inhibitors suppress proliferation in a human oesophageal adenocarcinoma cell line (OE33) by inducing apoptosis and cell cycle arrest.
Carcinogenesis 25:1945-1952
74. Devesa SS Blot WJ Fraumeni JF (1998) Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83:2049-2053 75. Bollschweiler E Wolfgarten E Gutschow C Hölscher AH (2001) Demographic
variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 92:549-555
76. Terry P Lagergren J Wolk A Nyrén O (2000) Reflux-inducing dietary factors and risk of adenocarcinoma of the esophagus and gastric cardia. Nutr Cancer 38:186-191
77. Kulig M Nocon M Vieth A Leodolter A Jaspersen D Labenz J Meyer-Sabellek W Stolte M Lind T Malfertheiner P Willich SN (2004) Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study. J Clin Epidemiol 57:580-589
78. Chen H Tucker KL Graubard BI Heineman EF Markin RS Potischman NA Russell RM Weisenburger DD Ward MH (2002) Nutrient intakes and adenocarcinoma of the esophagus and distal stomach. Nutr Cancer 42:33-40
79. Gammon MD Terry MB Arber N Chow W-H Risch HA Vaughan TL Schoenberg JB Mayne ST Stanford JL Dubrow R Rotterdam H West AB Fraumeni JF Weinstein IB Hibshoosh H (2004) Nonsteroidal anti-inflammatory drug use associated with reduced incidence of adenocarcinomas of the esophagus and gastric cardia that overexpress cyclin D1: a population-based study. Cancer Epidemiol Biomarkers Prev 13:34-39 80. Kubo A Corley DA (2004) Marked multi-ethnic variation of esophageal and gastric
cardia carcinomas within the United States. Am J Gastroenterol 99:582-588
81. Mayne ST Risch HA Dubrow R Chow W-H Gammon MD Vaughan TL Farrow DC Schoenberg JB Stanford JL Ahsan H West AB Rotterdam H Blot WJ Fraumeni JF (2001) Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 10:1055-1062
82. Lagergren J Bergström R Adami H-O Nyrén O (2000) Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med 133:165-175
83. Terry P Lagergren J Hansen H Wolk A Nyrén O (2001) Fruit and vegetable
consumption in the prevention of oesophageal and cardia cancers. Eur J Cancer Prev 10:365-369
84. Terry P Lagergren J Ye W Wolk A Nyrén O (2001) Inverse association between intake of cereal fiber and risk of gastric cardia cancer. Gastroenterology 120:387-391 85. Wolfgarten E Rosendahl U Nowroth T Leers J Metzger R Hölscher AH Bollschweiler
E (2001) Coincidence of nutritional habits and esophageal cancer in Germany. Onkologie 24:546-551
86. Banki F DeMeester SR Mason RJ Campos G Hagen JA Peters JH Bremner CG DeMeester TR (2005) Barrett's esophagus in females: A comparative analysis of risk factors in females and males. Am J Gastroenterol 100:560-567
87. Olliver JR Hardie LJ Gong Y Dexter S Chalmers D Harris KM Wild CP (2005) Risk factors, DNA damage, and disease progression in Barrett's esophagus. Cancer
Epidemiol Biomarkers Prev 14:620-625
88. Lord RV O'Grady R Sheehan C Field AF Ward RL (2000) K-ras codon 12 mutations
in Barrett's oesophagus and adenocarcinomas of the oesophagus and oesophagogastric junction. J Gastroenterol Hepatol 15:730-736
89. Doak SH Jenkins GJS Parry EM Griffiths AP Shah V Baxter JN Parry JM (2003) Characterisation of p53 status at the gene, chromosomal and protein levels in oesophageal adenocarcinoma. Br J Cancer 89:1729-1735
90. Vieth M Schneider-Stock R Röhrich K May A Ell C Markwarth A Roessner A Stolte M Tannapfel A (2004) INK4a-ARF alterations in Barrett's epithelium, intraepithelial neoplasia and Barrett's adenocarcinoma. Virchows Arch 445:135-141
91. Feith M Stein HJ Mueller J Siewert JR (2004) Malignant degeneration of Barrett's esophagus: the role of the Ki-67 proliferation fraction, expression of E-cadherin and p53. Dis Esophagus 17:322-327
92. Hardie JJ Darnton SJ Wallis YL Chauhan A Hainaut P Wild CP Casson AG (2005)
p16 expression in Barrett's esophagus and esophageal adenocarcinorna: association
93. Darnton SJ Hardie LJ Muc RS Wild CP Casson AG (2005) Tissue inhibitor of metalloproteinase-3 (TIMP-3) gene is methylated in the development of esophageal
adenocarcinoma: loss of expression correlates with poor prognosis. Int J Cancer 115:351-358
94. Kaur BS Ouatu-Lascar R Omary MB Triadafilopoulos G (2000) Bile salts induce or blunt cell proliferation in Barrett's esophagus in an acid-dependent fashion. Am J Physiol 278:G1000-G1009
95. Zhang F Subbaramaiah K Altorki N Dannenberg AJ (1998) Dihydroxy bile acids activate the transcription of cyclooxygenase-2. J Biol Chem 273:2424-2428
96. Wilson KT Fu S Ramanujam KS Meltzer SJ (1998) Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res 58:2929-2934
97. Speit G Witton-Davies T Heepchantree W Trenz K Hoffmann H (2003) Investigations on the effect of cigarette smoking in the comet assay. Mutat Res 542:33-42
98. Ellahuene MF Peréz-Alzola LP Farfán-Urzua M González-Hormazabal P Garay M Olmedo MI Last JA (2004) Preliminary evaluation of DNA damage related with the smoking habit measured by the comet assay in whole blood cells. Cancer Epidemiol Biomarkers Prev 13:1223-1229
99. Wolz L Krause G Scherer G Aufderheide M Mohr U (2002) In vitro genotoxicity assay of sidestream smoke using a human bronchial epithelial cell line. Food Chem Toxicol 40:845-850
100. Annas A Brittebo E Hellman B (2000) Evaluation of benzo(a)pyrene-induced DNA damage in human endothelial cells using alkaline single cell gel electrophoresis. Mutat Res 471:145-155
101. Gábelová A Binková B Valovicová Z Srám RJ (2004) DNA adduct formation by 7H-
dibenzo[c,g]carbazole and its tissue- and organ-specific derivatives in Chinese
hamster V79 cell lines stably expressing cytochrome P450 enzymes. Environ Mol Mutagen 44:448-458
102. Harréus UA Kleinsasser NH Zieger S Wallner B Reiter M Schuller P Berghaus A (2004) Sensitivity to DNA-damage induction and chromosomal alterations in mucosa cells from patients with and without cancer of the oropharynx detected by a
combination of Comet assay and fluorescence in situ hybridization. Mutat Res 563:131-138
103. Rajaee-Behbahani N Schmezer P Risch A Rittgen W Kayser KW Dienemann H Schulz V Drings P Thiel S Bartsch H (2001) Altered DNA repair capacity and bleomycin sensitivity as risk markers for non-small cell lung cancer. Int J Cancer 95:86-91
104. Hoffmann D Brunnemann KD Prokopczyk B Djordjevic MV (1994) Tobacco-specific
N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry,
carcinogenicity, and relevance to humans. J Toxicol Environ Health 41:1-52
105. Klus H Kuhn H (1982) Verteilung verschiedener Tabakrauchbestandteile auf Haupt- und Nebenstromrauch (Eine Übersicht). Beitr Tabakforsch Int 11:229-265
106. Carmella SG Borukhova A Desai D Hecht SS (1997) Evidence for endogenous formation of tobacco-specific nitrosamines in rats treated with tobacco alkaloids and sodium nitrite. Carcinogenesis 18:587-592
107. Atawodi SE Lea S Nyberg F Mukeria A Constantinescu V Ahrens W Brueske- Hohlfeld I Fortes C Boffetta P Friesen MD (1998) 4-hydroxy-1-(3-pyridyl)-1-
butanone-hemoglobin adducts as biomarkers of exposure to tobacco smoke: validation of a method to be used in multicenter studies. Cancer Epidemiol Biomarkers Prev 7:817-821
108. Branner B Kutzer C Zwickenpflug W Scherer G Heller WD Richter E (1998) Haemoglobin adducts from aromatic amines and tobacco-specific nitrosamines in pregnant smoking and nonsmoking women. Biomarkers 3:35-47
109. Carmella SG Kagan SS Kagan M Foiles PG Palladino G Quart AM Quart E Hecht SS (1990) Mass spectrometric analysis of tobacco-specific nitrosamine hemoglobin adducts in snuff-dippers, smokers, and non-smokers. Cancer Res 50:5438-5445 110. Falter B Kutzer C Richter E (1994) Biomonitoring of hemoglobin adducts: aromatic
amines and tobacco-specific nitrosamines. Clin Invest 72:364-371
111. Carmella SG Akerkar S Hecht SS (1993) Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers' urine. Cancer Res 53:721-724
112. Meger M Meger-Kossien I Riedel K Scherer G (2000) Biomonitoring of
environmental tobacco smoke (ETS)-related exposure to 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone (NNK). Biomarkers 5:33-45
113. Richter E (1996) Haemoglobin adducts of N-nitroso compounds. Eur J Cancer Prev 5:115-119
114. Burton HR Dye NK Bush LP (1992) Distribution of tobacco constituents in tobacco leaf tissue .1. Tobacco-specific nitrosamines, nitrate, nitrite, and alkaloids. J Agric Food Chem 40:1050-1055
115. Brunnemann KD Qi J Hoffmann D (2002) Chemical profile of two types of oral snuff tobacco. Food Chem Toxicol 40:1699-1703
116. Jenkins RA Palausky A Counts RW Bayne CK Dindal AB Guerin MR (1996) Exposure to environmental tobacco smoke in sixteen cities in the United States as determined by personal breathing zone air sampling. J Expos Anal Environ Epidemiol 6:473-502
117. Dempsey D Tutka P Jacob P Allen F Schoedel K Tyndale RF Benowitz NL (2004) Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clin Pharmacol Ther 76:64-72
118. Glas S (2003) Autoradiographische Untersuchungen zur Toxikokinetik von Myosmin in Ratten. Dissertation an der Tierärztlichen Fakultät der Ludwig-Maximilians-
Universität München
119. Richter E Schlöbe D Hölzle D Wilp J (2002) Comparative DNA and hemoglobin adduct formation by dietary myosmine and N'-nitrosonornicotine in rats. Naunyn
Schmiedebergs Arch Pharmacol 365 (Suppl.1):R140
120. Chen X Ding YW Yang G-Y Bondoc F Lee M-J Yang CS (2000) Oxidative damage in an esophageal adenocarcinoma model with rats. Carcinogenesis 21:257-263 121. Sihvo EIT Salminen JT Rantanen TK Rämö OJ Ahotupa M Färkkilä M Auvinen MI
Salo JA (2002) Oxidative stress has a role in malignant transformation in Barrett's oesophagus. Int J Cancer 102:551-555
122. Bentz BG Simmons RL Haines GK Radosevich JA (2000) The yin and yang of nitric